In this article, we will discuss Etoposide (Postmarketing Experience). So, let’s get started.
The following adverse reactions have been identified during post-approval use of etoposide. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug
Extravasation, resulting in local soft tissue toxicity, was identified in postmarketing reports. Extravasation of etoposide may result in swelling, pain, cellulitis, and necrosis including skin necrosis.